Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 87

Related Citations for PubMed (Select 23782727)

1.

How much diffusion lesion reversal occurs after treatment within three-hours of stroke onset?

Campbell BC, Davis SM, Donnan GA.

Int J Stroke. 2013 Jul;8(5):329-30. doi: 10.1111/ijs.12101.

PMID:
23782727
2.

Early ischaemic diffusion lesion reduction in patients treated with intravenous tissue plasminogen activator: infrequent, but significantly associated with recanalization.

Sakamoto Y, Kimura K, Shibazaki K, Inoue T, Uemura J, Aoki J, Sakai K, Iguchi Y.

Int J Stroke. 2013 Jul;8(5):321-6. doi: 10.1111/j.1747-4949.2012.00902.x. Epub 2012 Sep 27.

PMID:
23013151
3.

Ischemic diffusion lesion reversal is uncommon and rarely alters perfusion-diffusion mismatch.

Chemmanam T, Campbell BC, Christensen S, Nagakane Y, Desmond PM, Bladin CF, Parsons MW, Levi CR, Barber PA, Donnan GA, Davis SM; EPITHET Investigators.

Neurology. 2010 Sep 21;75(12):1040-7. doi: 10.1212/WNL.0b013e3181f39ab6. Epub 2010 Aug 18.

PMID:
20720188
4.

Monitoring intravenous recombinant tissue plasminogen activator thrombolysis for acute ischemic stroke with diffusion and perfusion MRI.

Schellinger PD, Jansen O, Fiebach JB, Heiland S, Steiner T, Schwab S, Pohlers O, Ryssel H, Sartor K, Hacke W.

Stroke. 2000 Jun;31(6):1318-28.

5.

The infarct core is well represented by the acute diffusion lesion: sustained reversal is infrequent.

Campbell BC, Purushotham A, Christensen S, Desmond PM, Nagakane Y, Parsons MW, Lansberg MG, Mlynash M, Straka M, De Silva DA, Olivot JM, Bammer R, Albers GW, Donnan GA, Davis SM; EPITHET–DEFUSE Investigators.

J Cereb Blood Flow Metab. 2012 Jan;32(1):50-6. doi: 10.1038/jcbfm.2011.102. Epub 2011 Jul 20.

6.

Remote ischemic perconditioning in thrombolysed stroke patients: randomized study of activating endogenous neuroprotection - design and MRI measurements.

Hougaard KD, Hjort N, Zeidler D, Sørensen L, Nørgaard A, Thomsen RB, Jonsdottir K, Mouridsen K, Hansen TM, Cho TH, Nielsen TT, Bøtker HE, Østergaard L, Andersen G.

Int J Stroke. 2013 Feb;8(2):141-6. doi: 10.1111/j.1747-4949.2012.00786.x. Epub 2012 Mar 30.

PMID:
22463392
7.
8.

CT perfusion identifies increased salvage of tissue in patients receiving intravenous recombinant tissue plasminogen activator within 3 hours of stroke onset.

Silvennoinen HM, Hamberg LM, Lindsberg PJ, Valanne L, Hunter GJ.

AJNR Am J Neuroradiol. 2008 Jun;29(6):1118-23. doi: 10.3174/ajnr.A1039. Epub 2008 Apr 10.

9.

Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.

Higashida RT, Furlan AJ, Roberts H, Tomsick T, Connors B, Barr J, Dillon W, Warach S, Broderick J, Tilley B, Sacks D; Technology Assessment Committee of the American Society of Interventional and Therapeutic Neuroradiology; Technology Assessment Committee of the Society of Interventional Radiology.

Stroke. 2003 Aug;34(8):e109-37. Epub 2003 Jul 17. Erratum in: Stroke. 2003 Nov;34(11):2774.

10.

Thrombolytic reversal of acute human cerebral ischemic injury shown by diffusion/perfusion magnetic resonance imaging.

Kidwell CS, Saver JL, Mattiello J, Starkman S, Vinuela F, Duckwiler G, Gobin YP, Jahan R, Vespa P, Kalafut M, Alger JR.

Ann Neurol. 2000 Apr;47(4):462-9.

PMID:
10762157
11.

Apparent diffusion coefficient thresholds do not predict the response to acute stroke thrombolysis.

Loh PS, Butcher KS, Parsons MW, MacGregor L, Desmond PM, Tress BM, Davis SM.

Stroke. 2005 Dec;36(12):2626-31. Epub 2005 Nov 3.

12.

Large ischemic lesions on diffusion-weighted imaging done before intravenous tissue plasminogen activator thrombolysis predicts a poor outcome in patients with acute stroke.

Kimura K, Iguchi Y, Shibazaki K, Terasawa Y, Inoue T, Uemura J, Aoki J.

Stroke. 2008 Aug;39(8):2388-91. doi: 10.1161/STROKEAHA.107.510917. Epub 2008 Jun 5.

13.

Two tales: hemorrhagic transformation but not parenchymal hemorrhage after thrombolysis is related to severity and duration of ischemia: MRI study of acute stroke patients treated with intravenous tissue plasminogen activator within 6 hours.

Thomalla G, Sobesky J, Köhrmann M, Fiebach JB, Fiehler J, Zaro Weber O, Kruetzelmann A, Kucinski T, Rosenkranz M, Röther J, Schellinger PD.

Stroke. 2007 Feb;38(2):313-8. Epub 2007 Jan 4.

14.

Geography, structure, and evolution of diffusion and perfusion lesions in Diffusion and perfusion imaging Evaluation For Understanding Stroke Evolution (DEFUSE).

Olivot JM, Mlynash M, Thijs VN, Purushotham A, Kemp S, Lansberg MG, Wechsler L, Gold GE, Bammer R, Marks MP, Albers GW.

Stroke. 2009 Oct;40(10):3245-51. doi: 10.1161/STROKEAHA.109.558635. Epub 2009 Aug 13.

15.

Effect of intravenous thrombolysis on MRI parameters and functional outcome in acute stroke <6 hours.

Röther J, Schellinger PD, Gass A, Siebler M, Villringer A, Fiebach JB, Fiehler J, Jansen O, Kucinski T, Schoder V, Szabo K, Junge-Hülsing GJ, Hennerici M, Zeumer H, Sartor K, Weiller C, Hacke W; Kompetenznetzwerk Schlaganfall Study Group.

Stroke. 2002 Oct;33(10):2438-45.

17.

Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.

Chung JW, Kim KJ, Noh WY, Jang MS, Yang MH, Han MK, Kwon OK, Jung C, Kim JH, Oh CW, Lee JS, Lee J, Bae HJ.

Cerebrovasc Dis. 2013;35(5):461-8. doi: 10.1159/000350201. Epub 2013 May 31.

PMID:
23735898
18.

A multicentre, randomized, double-blinded, placebo-controlled Phase III study to investigate EXtending the time for Thrombolysis in Emergency Neurological Deficits (EXTEND).

Ma H, Parsons MW, Christensen S, Campbell BC, Churilov L, Connelly A, Yan B, Bladin C, Phan T, Barber AP, Read S, Hankey GJ, Markus R, Wijeratne T, Grimley R, Mahant N, Kleinig T, Sturm J, Lee A, Blacker D, Gerraty R, Krause M, Desmond PM, McBride SJ, Carey L, Howells DW, Hsu CY, Davis SM, Donnan GA; EXTEND investigators.

Int J Stroke. 2012 Jan;7(1):74-80. doi: 10.1111/j.1747-4949.2011.00730.x.

PMID:
22188854
19.

Diffusion- and perfusion-weighted MRI response to thrombolysis in stroke.

Parsons MW, Barber PA, Chalk J, Darby DG, Rose S, Desmond PM, Gerraty RP, Tress BM, Wright PM, Donnan GA, Davis SM.

Ann Neurol. 2002 Jan;51(1):28-37.

PMID:
11782981
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk